Actively Recruiting
The Global En Bloc Resection of Bladder Tumour Registry
Led by Chinese University of Hong Kong · Updated on 2024-01-23
2000
Participants Needed
2
Research Sites
417 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study aims to collect data on ERBT globally in order to clarify its role in the management of bladder cancer over a 5-year observation period.
CONDITIONS
Official Title
The Global En Bloc Resection of Bladder Tumour Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients 18 years old or older with informed consent
- Presence of bladder tumour undergoing transurethral ERBT
You will not qualify if you...
- Presence or previous history of upper tract urothelial carcinoma
- Presence of other active malignancy
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
North District Hospital
Hong Kong, Hong Kong
Actively Recruiting
2
Prince of Wales Hospital
Hong Kong, Hong Kong
Actively Recruiting
Research Team
J
Jeremy YC TEOH, FRCS(Ed) MBBS
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here